Insider Transactions in Q4 2023 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,179
-2.86%
|
$0
$0.49 P/Share
|
|
Nov 17
2023
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
9,646
-3.4%
|
$0
$0.49 P/Share
|
|
Nov 17
2023
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
19,877
-2.16%
|
$0
$0.49 P/Share
|